Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Muller, Y.D.; Aubert, J.D.; Vionnet, J.; Rotman, S.; Sadallah, S.; Aubert, V.; Pascual, M.

doi:10.1097/TP.0000000000002165

Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Détails

Télécharger: 29521880_pp_cover.pdf (493.82 [Ko])
Etat: Public
Version: Author's accepted manuscript
Licence: Non spécifiée

ID Serval

serval:BIB_A55614976F55

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Périodique

Transplantation

Auteur⸱e⸱s

Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M.

ISSN

1534-6080 (Electronic)

ISSN-L

0041-1337

Statut éditorial

Publié

Date de publication

06/2018

Peer-reviewed

Oui

Volume

102

Numéro

6

Pages

e301-e303

Langue

anglais

Notes

Publication types: Case Reports ; Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish

Mots-clé

Antibodies, Monoclonal, Humanized/therapeutic use, Drug Therapy, Combination, Female, Graft Rejection/diagnosis, Graft Rejection/drug therapy, Graft Rejection/immunology, Graft Survival/drug effects, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunosuppressive Agents/therapeutic use, Isoantibodies/immunology, Lung Transplantation/adverse effects, Middle Aged, Rituximab/therapeutic use, Time Factors, Treatment Outcome

URN

urn:nbn:ch:serval-BIB_A55614976F552

OAI-PMH

oai:serval.unil.ch:BIB_A55614976F55

DOI

10.1097/TP.0000000000002165

Pubmed

29521880

Web of science

000433905600010

Création de la notice

13/03/2018 9:34